Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
340 |
|
| Actual shortage: | 4 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 331 (97%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
50 (15%) |
|
Overdue reports |
2 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| POTASSIUM PHOSPHATES INJECTION, USP | 224MG 236MG | SOLUTION | Resolved | 2020-09-17 | 2021-01-26 | 124366 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2021-10-01 | 2021-10-22 | 146596 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2022-04-13 | 2022-11-03 | 158777 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2022-04-13 | 2022-05-02 | 158780 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2022-04-26 | 2023-04-13 | 159355 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2024-10-22 | 2024-12-03 | 240890 |
| PROTAMINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2019-07-26 | 2019-08-17 | 90060 |
| PROTAMINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-02-05 | 2021-04-13 | 133508 |
| PROTAMINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-02-05 | 2021-04-13 | 133511 |
| PROTAMINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-09-21 | 2021-12-01 | 145966 |
| PROTAMINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-11-26 | 2021-12-25 | 150090 |
| PROTAMINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-02-08 | 2022-03-04 | 154470 |
| PROTAMINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-03-09 | 2022-10-02 | 156322 |
| PROTAMINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-08-04 | 2022-09-12 | 166155 |
| PROTAMINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-07-27 | 2023-08-16 | 200334 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136455 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2 mg/mL | Solution | Resolved | 2018-06-06 | 2018-10-02 | 51680 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5 mg/mL | Solution | Resolved | 2018-06-06 | 2019-09-13 | 51683 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10 mg/mL | Solution | Resolved | 2018-06-06 | 2019-03-01 | 51686 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10 mg/mL | Solution | Resolved | 2018-06-06 | 2019-03-01 | 51691 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2